Consumer access to clozapine in Australia: how does this compare to New Zealand and the United Kingdom? | Zendy

Sally-Anne Knowles | Zendy; Sara S. McMillan | Zendy; Amanda Wheeler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Consumer access to clozapine in Australia: how does this compare to New Zealand and the United Kingdom?

Author(s) -

Sally-Anne Knowles,

Sara S. McMillan,

Amanda Wheeler

Publication year - 2016

Publication title -

pharmacy practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 24

eISSN - 1886-3655

pISSN - 1885-642X

DOI - 10.18549/pharmpract.2016.02.722

Subject(s) - clozapine , pharmacy , schizophrenia (object oriented programming) , descriptive statistics , psychiatry , medicine , sample (material) , community pharmacy , antipsychotic , psychology , geography , family medicine , business , statistics , chemistry , mathematics , chromatography

There are predominately two models for supply of clozapine to consumers living in the community in Australia, New Zealand and the United Kingdom. One model utilises secondary care facilities and the other community services. Community pharmacy is ideally placed to increase access to clozapine for consumers living in the community, provided appropriate training and support is given to pharmacists providing this professional service.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research